Patent · US Active

Synthesis of 5-azacytidine

US9951098B2 · kind B2 · utility

5Cited by

22References

35Claims

0Family size

Assignee

Pharmion LLC · US

Inventors

Chinnapillai Rajendiran · Hyderabad, IN
Periyandi Nagarajan · Hyderabad, IN
Jasti Venkateswarlau · Hyderabad, IN

Key dates

Filing date	Mar 29, 2012
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Mar 5, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are processes for the preparation of 5-azacytidine, useful for treating, preventing, and/or managing diseases or conditions including cancer, disorders related to abnormal cell proliferation, hematologic disorders, and myelodysplastic syndromes (MDS), wherein 5-azacytidine is represented by the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.